Aureka Biotechnologies
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
23181 Verdugo Dr Ste 106, Laguna Hills, ...Website
www.aurekabio.comRevenue
$9.5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
1
1
1
1
About Aureka Biotechnologies
Aureka Biotechnologies is an AI-native TechBio company building biological foundation models and closed-loop R&D infrastructure for drug discovery. Its platform combines generative AI, autonomous agents, proprietary experimental data and high-throughput wet-lab validation to design, test and optimize novel therapeutics, with a focus on transforming how complex biological systems are understood and engineered.Explore more
Aureka Biotechnologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aureka Biotechnologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Aureka Biotechnologies had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Aureka Biotechnologies
Check out if Aureka Biotechnologies is spiking on competitors!
Product Launch: Get notified when Aureka Biotechnologies launches new products
Funding: Get notified immidiatlly once Aureka Biotechnologies has new funding data
Aureka Biotechnologies, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Aureka Biotechnologies has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Aureka Biotechnologies recently announced quarterly report
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Aureka Biotechnologies is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Aureka Biotechnologies is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Aureka Biotechnologies.
Aureka Biotechnologies financials insights
Gather financial insights about Aureka Biotechnologies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Series A
$58.3M
Series B
$100M
Aureka Biotechnologies Tech Stack
A closer look at the technologies used by Aureka Biotechnologies
See more technologies
Aureka Biotechnologies News & Media
Aureka Biotechnologies Raises US$100 Million Series B to Build a Biological World Model for Drug Discovery
LAGUNA HILLS, Calif. and SHANGHAI, Aug. 10, 2026 /PRNewswire/ -- Aureka Biotechnologies announced the close of a US$100 million Series B financing on Aug. 10, 2026. Granite Asia funded the first tranche exclusively, and a prominent strategic investor led a subsequent tranche, with...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aureka Biotechnologies
Sign Up For FreeTo access detailed company insights
Aureka Biotechnologies is an AI-native TechBio company building biological foundation models and closed-loop R&D infrastructure for drug discovery. Its platform combines generative AI, autonomous agents, proprietary experimental data and high-throughput wet-lab validation to design, test and optimize novel therapeutics, with a focus on transforming... Read More
